DWM
SBFM

Dakota Wealth Management’s Sunshine Biopharma SBFM Stock Holding History

Dakota Wealth Management’s Portfolio SBFM Stock Details SBFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed -$22K – 607
2022
Q2 		$22K Buy
+1
New +$48.8K ﹤0.01% 509

Other funds holding SBFM

BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Dakota Wealth Management's SBFM Position: Q3 2022 in Review

Dakota Wealth Management sold out of Sunshine Biopharma (SBFM) in Q3 2022, closing a stake of 1 share — an estimated $22K sold.

Dakota Wealth Management first reported a position in SBFM in Q2 2022 and held it in 1 quarter. The position peaked at $22K in Q2 2022. 7 funds tracked by Wall St. Rank hold SBFM as of Q3 2022.

  • Dakota Wealth Management reported no remaining Sunshine Biopharma position as of Q3 2022 after selling out during the quarter.
  • Dakota Wealth Management sold 1 Sunshine Biopharma share in Q3 2022, an estimated $22K.
  • Dakota Wealth Management first reported a position in Sunshine Biopharma in Q2 2022 and held it in 1 quarter.
  • Dakota Wealth Management's Sunshine Biopharma position peaked at $22K in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q3 2022.

Based on Dakota Wealth Management's 13F filing for Q3 2022, filed 10 Nov 2022.